El Bahhaj and colleagues [210] developed polymeric micelle hybrid nanoparticles encapsulating HDAC inhibitors demonstrating significantly improved tumor accumulation and reduced systemic toxicity compared to free drug. This evidence concerns the gene HDAC9 and neoplasm.